{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:45:00Z","timestamp":1772725500726,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007353","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","award":["2017b-1711"],"award-info":[{"award-number":["2017b-1711"]}],"id":[{"id":"10.13039\/100007353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM19\/00149"],"award-info":[{"award-number":["CM19\/00149"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00634"],"award-info":[{"award-number":["PI19\/00634"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To describe congenital and acquired heart diseases in a Spanish cohort of adults with Down syndrome (DS), which could inform potential health recommendations for this population. Cross-sectional, observational study of adults with DS evaluated consecutively at a tertiary care, outpatient center between January 1 and December 31, 2019. The study population comprised 937 patients (51.8% men; median [IQR] age, 42 [18] years). An echocardiogram was available in the clinical chart of 420 patients (44.8%). The diagnosis of any form of heart disease was confirmed in 211 patients (22.5%): 101 (10.8%) had congenital heart defects, 80 (8.5%) simultaneous congenital and valvular heart diseases, and 30 (3.2%) isolated valvular heart disease. 111 patients (52.6% of those with congenital or valvular heart disease) had received corrective cardiac surgery. A total of 65 individuals were receiving medical management alone (30.8%), while 35 did not require any treatment because their cardiac disease was mild (16.6%). We found a high overall prevalence of heart disease in patients with DS, higher than previously reported for the pediatric population. Management of cardiovascular disease in adults with DS differs from that of the general population and should include universal echocardiography-based screening.<\/jats:p>","DOI":"10.1038\/s41598-022-26918-0","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T11:07:54Z","timestamp":1672225674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of congenital and acquired heart diseases in a Spanish cohort of adults with Down syndrome"],"prefix":"10.1038","volume":"12","author":[{"given":"Laura","family":"Rabes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ad\u00e1n-Lirola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Pilar","family":"Gonz\u00e1lez-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Galv\u00e1n-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Moldenhauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Roy-Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Real de As\u00faa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"issue":"24","key":"26918_CR1","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1056\/NEJMra1706537","volume":"382","author":"MJ Bull","year":"2020","unstructured":"Bull, M. J. Down syndrome. N. Engl. J. Med. 382(24), 2344\u20132352 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"26918_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21470\/1678-9741-2018-0358","volume":"34","author":"FCGB Santos","year":"2019","unstructured":"Santos, F. C. G. B. et al. Surgical treatment for congenital heart defects in down syndrome patients. Braz. J. Cardiovasc. Surg. 34(1), 1\u20137 (2019).","journal-title":"Braz. J. Cardiovasc. Surg."},{"issue":"5","key":"26918_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0039-6257(90)90116-D","volume":"34","author":"RA Catalano","year":"1990","unstructured":"Catalano, R. A. Down syndrome. Surv. Ophthalmol. 34(5), 385\u2013398 (1990).","journal-title":"Surv. Ophthalmol."},{"issue":"4","key":"26918_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1469-8749.2004.tb00483.x","volume":"46","author":"AH Bittles","year":"2004","unstructured":"Bittles, A. H. & Glasson, E. J. Clinical, social, and ethical implications of changing life expectancy in down syndrome. Dev. Med. Child Neurol. 46(4), 282\u2013286 (2004).","journal-title":"Dev. Med. Child Neurol."},{"issue":"1","key":"26918_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/gim.2012.93","volume":"15","author":"JL Zhu","year":"2013","unstructured":"Zhu, J. L. et al. Survival among people with down syndrome: A nationwide population-based study in Denmark. Genet Med. 15(1), 64\u201369 (2013).","journal-title":"Genet Med."},{"issue":"2","key":"26918_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/eurpub\/ckl103","volume":"17","author":"AH Bittles","year":"2007","unstructured":"Bittles, A. H. et al. The four ages of Down syndrome. Eur. J. Public Health. 17(2), 221\u2013225 (2007).","journal-title":"Eur. J. Public Health."},{"issue":"5","key":"26918_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1034\/j.1399-0004.2002.620506.x","volume":"62","author":"EJ Glasson","year":"2002","unstructured":"Glasson, E. J. et al. The changing survival profile of people with down\u2019s syndrome: Implications for genetic counselling. Clin. Genet. 62(5), 390\u2013393 (2002).","journal-title":"Clin. Genet."},{"issue":"9","key":"26918_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137093","volume":"10","author":"CG Sobey","year":"2015","unstructured":"Sobey, C. G. et al. Risk of major cardiovascular events in people with down syndrome. PLoS ONE 10(9), e0137093 (2015).","journal-title":"PLoS ONE"},{"issue":"18","key":"26918_CR9","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1136\/hrt.2010.197509","volume":"96","author":"JC Vis","year":"2010","unstructured":"Vis, J. C. et al. Congenital heart defects are under-recognised in adult patients with down\u2019s syndrome. Heart 96(18), 1480\u20131484 (2010).","journal-title":"Heart"},{"key":"26918_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijcard.2017.03.040","volume":"241","author":"SA Hayes","year":"2017","unstructured":"Hayes, S. A. et al. Cardiovascular and general health status of adults with trisomy 21. Int. J. Cardiol. 241, 173\u2013176 (2017).","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"26918_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ajmg.a.38512","volume":"176","author":"GT Capone","year":"2018","unstructured":"Capone, G. T. et al. Co-occurring medical conditions in adults with down syndrome: A systematic review toward the development of health care guidelines. Am. J. Med. Genet A. 176(1), 116\u2013133 (2018).","journal-title":"Am. J. Med. Genet A."},{"issue":"15","key":"26918_CR12","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1001\/jama.2020.17024","volume":"324","author":"AY Tsou","year":"2020","unstructured":"Tsou, A. Y. et al. Medical care of adults with down syndrome. JAMA 324(15), 1543\u20131556 (2020).","journal-title":"JAMA"},{"issue":"2","key":"26918_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/clc.20864","volume":"34","author":"T Raina","year":"2011","unstructured":"Raina, T., McGrath, E. & Gunn, J. Myocardial infarction in a patient with down syndrome: A case report and review of the literature. Clin. Cardiol. 34(2), 87\u201389 (2011).","journal-title":"Clin. Cardiol."},{"issue":"6081","key":"26918_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/bmj.2.6081.226","volume":"2","author":"JC Murdoch","year":"1977","unstructured":"Murdoch, J. C. et al. Down\u2019s syndrome: An atheroma-free model?. Br Med J. 2(6081), 226\u2013228 (1977).","journal-title":"Br Med J."},{"issue":"2\u20133","key":"26918_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0021-9150(89)90110-X","volume":"76","author":"S Yl\u00e4-Herttuala","year":"1989","unstructured":"Yl\u00e4-Herttuala, S., Luoma, J., Nikkari, T. & Kivim\u00e4ki, T. Down\u2019s syndrome and atherosclerosis. Atherosclerosis 76(2\u20133), 269\u2013272 (1989).","journal-title":"Atherosclerosis"},{"key":"26918_CR16","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"33","author":"B Williams","year":"2018","unstructured":"Williams, B. et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European society of cardiology (ESC) and the European society of hypertension (ESH). Eur. Heart J. 33, 3021\u20133104 (2018).","journal-title":"Eur. Heart J."},{"issue":"S1","key":"26918_CR17","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. 2 Classification and diagnosis of diabetes: Standards of medical care in diabetes-2020. Diab. Care. 43(S1), S14\u2013S31 (2020).","journal-title":"Diab. Care."},{"issue":"1","key":"26918_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach, F. et al. 2019 ESC\/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk: The task force for the management of dyslipidemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS). Eur. Heart J. 41(1), 111\u2013188 (2020).","journal-title":"Eur. Heart J."},{"issue":"Suppl 2","key":"26918_CR19","first-page":"S51","volume":"6","author":"National Institutes of Health","year":"1998","unstructured":"National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obes. Res. 6(Suppl 2), S51\u2013S209 (1998).","journal-title":"Obes. Res."},{"issue":"34","key":"26918_CR20","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren, F. L. J. et al. 2021 ESC\/ESH guidelines on cardiovascular disease prevention in clinical practice: Developed by the task force for cardiovascular disease prevention in clinical practice with representatives of the European society of cardiology and 12 medical societies with the special contribution of the European association of preventive cardiology (EAPC). Eur. Heart J. 42(34), 3227\u20133337 (2021).","journal-title":"Eur. Heart J."},{"issue":"20","key":"26918_CR21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association Declaration of Helsinki","year":"2013","unstructured":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA 310(20), 2191\u20132194 (2013).","journal-title":"JAMA"},{"issue":"3","key":"26918_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/GIM.0b013e3181634867","volume":"10","author":"SB Freeman","year":"2008","unstructured":"Freeman, S. B. et al. Ethnicity, sex, and the incidence of congenital heart defects: A report from the national down syndrome project. Genet Med. 10(3), 173\u2013180 (2008).","journal-title":"Genet Med."},{"issue":"2","key":"26918_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/(SICI)1096-8628(19961016)65:2<160::AID-AJMG16>3.0.CO;2-O","volume":"65","author":"B K\u00e4ll\u00e9n","year":"1996","unstructured":"K\u00e4ll\u00e9n, B., Mastroiacovo, P. & Robert, E. Major congenital malformations in down syndrome. Am. J. Med. Genet. 65(2), 160\u2013166 (1996).","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"26918_CR24","first-page":"44","volume":"41","author":"C Stoll","year":"1998","unstructured":"Stoll, C., Alembik, Y., Dott, B. & Roth, M. P. Study of Down syndrome in 238,942 consecutive births. Ann. Genet. 41(1), 44\u201351 (1998).","journal-title":"Ann. Genet."},{"key":"26918_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/(SICI)1096-8628(19980605)77:5<431::AID-AJMG15>3.0.CO;2-J","volume":"77","author":"CP Torfs","year":"1998","unstructured":"Torfs, C. P. & Christianson, R. E. Anomalies in down syndrome individuals in a large population-based registry. Am. J. Med. Genet. 77, 431\u2013438 (1998).","journal-title":"Am. J. Med. Genet."},{"key":"26918_CR26","unstructured":"Down Espa\u00f1a. Programa de Espa\u00f1ol de Salud para personas con s\u00edndrome de Down. 2021. Available at: https:\/\/www.sindromedown.net\/area\/salud\/."},{"issue":"7","key":"26918_CR27","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.amjcard.2012.12.025","volume":"111","author":"F Baraona","year":"2013","unstructured":"Baraona, F., Gurvitz, M., Landzberg, M. J. & Opotowsky, A. R. Hospitalizations and mortality in the United States for adults with down syndrome and congenital heart disease. Am. J. Cardiol. 111(7), 1046\u20131051 (2013).","journal-title":"Am. J. Cardiol."},{"key":"26918_CR28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3122\/jabfm.2020.06.190425","volume":"33","author":"V Fitzpatrick","year":"2020","unstructured":"Fitzpatrick, V., Rivelli, A., Bria, K. & Chicoine, B. Heart disease in adults with down syndrome between 1996 and 2016. J. Am. Board Fam. Med. 33, 923\u2013931 (2020).","journal-title":"J. Am. Board Fam. Med."},{"issue":"5","key":"26918_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.rce.2019.09.003","volume":"220","author":"E Roy-Vallejo","year":"2020","unstructured":"Roy-Vallejo, E. et al. Hemodynamic profile of Spanish adults with down syndrome. Rev. Clin. Esp. 220(5), 275\u2013281 (2020).","journal-title":"Rev. Clin. Esp."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26918-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26918-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26918-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T10:03:33Z","timestamp":1672481013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26918-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["26918"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-26918-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"26 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22461"}}